What my attention has been on since earlier this year is what was included in the presentation below under Key Strategic Objectives on page 20 dot point # 3 below...
"Accelerate path to clinical development by global repositioning of the company".
http://www.asx.com.au/asxpdf/20150409/pdf/42xsnqz22tkqsx.pdf
I wonder whether part of the funds highlighted on point #4 on page 13 of the recent Prospectus be used towards this?
Tony
What my attention has been on since earlier this year is what...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13987 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 1380 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |